McKesson Corp

Pharmaceuticals

MCK

$ 323 1.2

Share price

$ 47 bn

Market Cap

$ 51 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.18x the weighted average for S&P 500

FY2021

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

McKesson Corp reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 March 2021 at 265 Kt (+9.6/+3.7% y-o-y). Carbon intensity also remained unchnaged at 1.1 t.

McKesson Corp's Scope 3 emissions remained unchnaged at 114,419 Kt. The parameter has been fairly volatile.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Date	Total CO2e emissions (market-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2021Q1	265	115	150	114,419	238,228	1.1
2020Q1	255	104	151	114,428	231,051	1.1
2019Q1	317	143	173	67	214,319	1.5
2018Q1	303	125	178	76	208,357	1.5

McKesson Corp

Carbon footprint

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

McKesson Corp's carbon footprint

Company environmental metrics